节点文献
尿激酶型纤溶酶原激活剂及其抑制剂PAI-1 mRNAs的表达与人肝细胞癌的关系
RELATIONSHIP BETWEEN THE EXPRESSION OF UROKINASE TYPE PLASMINOGEN ACTIVATOR AND ITS INHIBITOR TYPE 1 mRNAs AND THE BEHAVIOR OF HUMAN HEPATOCELLULAR CARCINOMA
【摘要】 为探讨尿激酶型纤溶酶原激活剂(uPA)及其抑制剂PAI-1mRNAs的表达变化与人肝细胞癌(HCC)浸润、转移间的关系,应用Northern印迹杂交技术对30例新鲜活检肝组织作uPA和PAI-1mRNAs表达的研究。结果显示:16例伴肝内浸润和转移癌组织中uPA和PAI-1mRNAs表达水平明显高于14例无肝内浸润和转移肝组织;18例高分化HCC癌组织与12例中、低分化HCC相比,uPA和PAI-1mRNAs含量差异有显著性意义。结果表明,癌组织内uPA和PAI-1基因转录水平的改变与HCC浸润、转移及细胞分化密切相关。
【Abstract】 To study the relationship between the changes in urokinase molecular system and human hepatocellular carcinoma, the expression of urokinase type plasminogen activator (uPA) and its inhibitor type 1 (PAI 1) mRNAs was analysed by using Northern blot method in 30 biopsied HCC tissues with intrahepatic invasion and metastasis and those without invasion and metastasis. Increased expression of uPA and PAI 1 mRNAs was noted in poorly differentiated HCC when compared with that in well differentiated HCC. It is concluded that the changes in expression of uPA and PAI 1 mRNAs may be related to HCC invasion, metastasis and cell differentiation.
【Key words】 carcinoma,hepatocellular; plasminogen activators; urokinase; plasminogen activator inhibitor 1;
- 【文献出处】 解放军医学杂志 ,MEDICAL JOURNAL OF CHINESE PEOPLE’S LIBERATION ARMY , 编辑部邮箱 ,1999年02期
- 【被引频次】2
- 【下载频次】36